NYSE ARCA | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 5.7% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 5.62% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 5.18% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.68% |
| GSK | GlaxoSmithKline PLC | Healthcare | Drug Manufacturers - General | 4.33% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.1% |
| SAN | Sanofi SA | Healthcare | Drug Manufacturers - General | 4.01% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 4.01% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 3.61% |
| 4502 | Takeda Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - Specialty & Generic | 3.49% |
| GMAB | Genmab A/S | Healthcare | Biotechnology | 3.36% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 3.35% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 3.29% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.15% |
| 6160 | Beigene Ltd | Healthcare | Biotechnology | 3.14% |
| IOVA | Iovance Biotherapeutics Inc | Healthcare | Biotechnology | 3.02% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 2.93% |
| GERN | Geron Corporation | Healthcare | Biotechnology | 2.32% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 2.28% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 2.24% |
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.